Shah, Hemali http://orcid.org/0000-0002-8407-9339
Parisi, Rose http://orcid.org/0000-0003-2454-6895
Mukherjee, Eric http://orcid.org/0000-0001-8715-1378
Phillips, Elizabeth J. http://orcid.org/0000-0002-7623-3383
Dodiuk-Gad, Roni P. http://orcid.org/0000-0003-2168-3798
Article History
Accepted: 25 August 2024
First Online: 15 September 2024
Declarations
:
: R.P.D.G. consults for Janssen, Sanofi, AbbVie, Novartis, Pfizer, La Roche-Posay, Dexcel, Eli Lilly, and Devintec Pharma. E.J.P. receives royalties and consulting fees from UpToDate and consulting fees from Janssen, Verve, Esperion, Servier, and RAPT independent from the submitted work. R.P., H.S., E.M. have no relevant conflicts of interest to disclose.
: No specific funding was received for the preparation of this manuscript.
: Not applicable.
: Patient consent was received for photo publication.
: Not applicable.
: All authors contributed to the study conceptualization, literature search and data analysis, writing—original draft preparation, writing—review and editing, and supervision. All authors have read and agreed to the published version of the manuscript.
: Data derived from public resources and made available with the article.